STORM development plan update:
STORM development plan update:
- Phase 1: Pilot (20 patients) for model training and logistics validation. Estimated cost: USD 1,000-1,500.
- Phase 2: Genetic expansion (100 patients) to generate novel genotype data. Estimated cost: USD 4,000-6,000.
- Phase 3: Genotype + outcomes (200 patients) to link genetics with clinical response. Estimated cost: USD 8,000-12,000.
- Phase 4: Publication with data analysis, update, and a peer-reviewed manuscript. Estimated cost: USD 2,000-5,000.
- Phase 5: Commercial prototype with the first 100 saliva kits for sale. Estimated cost: USD 5,000-10,000.
Primary objective: Build the first Mexican pharmacogenomic frequency database in rheumatic patients. Clinical endpoint: Concordance between predicted genotype and therapeutic response at 12 months.
Next step: define the pilot IRB, sample collection workflow, and publication plan.